Osteoprotegerin Reduces Osteoclast Numbers and Prevents Bone Erosion in Collagen-Induced Arthritis
Natalie Sims
The American Journal of Pathology, 2002
View PDFchevron_right
RANK, RANKL and osteoprotegerin in arthritic bone loss
Jozélio Carvalho
Brazilian Journal of Medical and Biological Research, 2005
View PDFchevron_right
Expression of osteoclast differentiation factor at sites of bone erosion in collagen‐induced arthritis
Vecky Martin
Arthritis & …, 2000
View PDFchevron_right
TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand
Osami Kanagawa
Journal of Clinical Investigation, 2000
View PDFchevron_right
Additive bone-protective effects of anabolic treatment when used in conjunction with RANKL and tumor necrosis factor inhibition in two rat arthritis models
Brad Bolon
Arthritis and Rheumatism, 2005
View PDFchevron_right
Tumor necrosis factor-alpha: Alternative role as an inhibitor of osteoclast formation in vitro
Christoph Mueller
Bone, 2006
View PDFchevron_right
Inhibitory Effects of Gold and Silver Nanoparticles on the Differentiation into Osteoclasts In Vitro
seil sohn
Pharmaceutics
View PDFchevron_right
Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice
Brad Bolon
Arthritis and Rheumatism, 2003
View PDFchevron_right
RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFα or anti-IL-1 therapies
Marina Stolina
Arthritis Research & Therapy, 2009
View PDFchevron_right
Osteoprotegerin, an endogenous antiosteoclast factor for protecting bone in rheumatoid arthritis
Brad Bolon
Arthritis and Rheumatism, 2002
View PDFchevron_right
Bone sparing effect of osteoprotegerin and anti-inflammatory cytokines in collagen-induced arthritis
Martine Cohen-solal
Arthritis Research & …, 2003
View PDFchevron_right
The effect of TNFα secreted from macrophages activated by titanium particles on osteogenic activity regulated by WNT/BMP signaling in osteoprogenitor cells
Byung-Soo Choi
Biomaterials, 2012
View PDFchevron_right
Recombinant receptor activator of nuclear factor�κB exhibits more marked inhibitory effects on osteoclasts compared with recombinant osteoprotegerin in�vitro and in�vivo
Licheng Zhang
Molecular Medicine Reports, 2012
View PDFchevron_right
The Inhibition of RANKL-Induced Osteoclastogenesis through the Suppression of p38 Signaling Pathway by Naringenin and Attenuation of Titanium-Particle-Induced Osteolysis
Yuanqing Mao
International Journal of Molecular Sciences, 2014
View PDFchevron_right
Tumor necrosis factor ?-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin
Colin Dunstan
Arthritis & Rheumatism, 2002
View PDFchevron_right
Therapeutic targeting of osteoclasts by osteoprotegerin and bisphosphonates leads to a reduction of TNFalpha-mediated bone resorption
Colin Dunstan
Arthritis Research & Therapy, 2001
View PDFchevron_right
Pathological role of osteoclast costimulation in arthritis-induced bone loss
Sae Ochi
Proceedings of the National Academy of Sciences, 2007
View PDFchevron_right
The increased in vitro osteoclastogenesis in patients with rheumatoid arthritis is due to increased percentage of precursors and decreased apoptosis — The In Vitro Osteoclast Differentiation in Arthritis (IODA) study
Lukasz Kurgan, Gilles Boire
Bone, 2011
View PDFchevron_right
Costimulatory blockade to prevent osteoclastogenesis, inflammation, or both?
Julia Charles
IBMS BoneKEy, 2010
View PDFchevron_right
The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells
Johanne Martel-pelletier
Clinical and experimental rheumatology
View PDFchevron_right
Tumor necrosis factor α activation of the apoptotic cascade in murine articular chondrocytes is associated with the induction of metalloproteinases and specific pro-resorptive factors
L. Gerstenfeld
Arthritis & Rheumatism, 2003
View PDFchevron_right
TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand
Osami Kanagawa
Journal of Clinical …, 2000
View PDFchevron_right
Granzyme A Contributes to Inflammatory Arthritis in Mice Through Stimulation of Osteoclastogenesis
Victor gonzalez rumayor
Arthritis & Rheumatology, 2017
View PDFchevron_right
The role of bone in the treatment of osteoarthritis
Daniel Lajeunesse
2004
View PDFchevron_right
TNF-α antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis
M. Cohen-solal
Bone, 2004
View PDFchevron_right
Kinetics of bone protection by recombinant osteoprotegerin therapy in Lewis rats with adjuvant arthritis
Brad Bolon
Arthritis and Rheumatism, 2002
View PDFchevron_right
Targeting Bone Alleviates Osteoarthritis in Osteopenic Mice and Modulates Cartilage Catabolism
Frédéric Lioté
PLoS ONE, 2012
View PDFchevron_right
The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis
Tania Crotti
The Journal of Bone and Joint Surgery, 2001
View PDFchevron_right
Tumor necrosis factor ? activation of the apoptotic cascade in murine articular chondrocytes is associated with the induction of metalloproteinases and specific pro-resorptive factors
Cory Edgar
Arthritis & Rheumatism, 2003
View PDFchevron_right
The molecular mechanism of osteoclastogenesis in rheumatoid arthritis
Nobuyuki Udagawa
Arthritis research, 2002
View PDFchevron_right
The combination of pamidronate and calcitriol reverses particle- and TNF-α-induced altered functions of bone-marrow-derived stromal cells with osteoblastic phenotype
Chandrasekaran Raman
The Journal of Bone and Joint Surgery, 2004
View PDFchevron_right